Dentsply Sirona Q4 Adjusted EPS $0.44 Beats $0.43 Estimate, Sales $1.01B Beat $976.87M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dentsply Sirona (NASDAQ:XRAY) reported Q4 adjusted EPS of $0.44, surpassing the $0.43 estimate, and sales of $1.01B, exceeding the $976.87M estimate. This represents a 4.35% decrease in EPS and a 2.95% increase in sales from the same period last year.
February 29, 2024 | 11:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dentsply Sirona reported a Q4 adjusted EPS of $0.44, beating estimates, and sales of $1.01B, also above expectations. EPS saw a 4.35% decrease, while sales grew by 2.95% YoY.
Beating both EPS and sales estimates typically has a positive impact on investor sentiment and stock price in the short term. The decrease in EPS might temper some enthusiasm, but the overall positive results and sales growth suggest a likely positive short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100